From Multivalency to Biomarker-Guided Delivery: Integrating Breakthroughs for the Future of Targeted Protein Degradation.

Elkhalifa MA, Kargbo RB

Open source

DOI
10.1021/acsmedchemlett.5c00734
Published
2026 Jan 8
Container
ACS medicinal chemistry letters
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsmedchemlett.5c00734,
  title = {From Multivalency to Biomarker-Guided Delivery: Integrating Breakthroughs for the Future of Targeted Protein Degradation.},
  author = {Elkhalifa MA and Kargbo RB},
  year = {2026},
  journal = {ACS medicinal chemistry letters},
  doi = {10.1021/acsmedchemlett.5c00734},
  url = {https://doi.org/10.1021/acsmedchemlett.5c00734}
}

RIS

TY  - JOUR
TI  - From Multivalency to Biomarker-Guided Delivery: Integrating Breakthroughs for the Future of Targeted Protein Degradation.
AU  - Elkhalifa MA
AU  - Kargbo RB
PY  - 2026
JO  - ACS medicinal chemistry letters
DO  - 10.1021/acsmedchemlett.5c00734
UR  - https://doi.org/10.1021/acsmedchemlett.5c00734
ER  - 

APA

MA, E., & RB, K. (2026). From Multivalency to Biomarker-Guided Delivery: Integrating Breakthroughs for the Future of Targeted Protein Degradation.. ACS medicinal chemistry letters. https://doi.org/10.1021/acsmedchemlett.5c00734

Source records